188 related articles for article (PubMed ID: 9141210)
1. Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity.
Baldridge JR; Ward JR
Vaccine; 1997 Mar; 15(4):395-401. PubMed ID: 9141210
[TBL] [Abstract][Full Text] [Related]
2. Induction by killed Listeria monocytogenes of effector T cells mediating delayed-type hypersensitivity but not protection in mice.
Koga T; Mitsuyama M; Handa T; Yayama T; Muramori K; Nomoto K
Immunology; 1987 Oct; 62(2):241-8. PubMed ID: 2445666
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the adjuvant activity of naloxone, an opioid receptor antagonist, in combination with heat-killed Listeria monocytogenes vaccine.
Jazani NH; Karimzad M; Mazloomi E; Sohrabpour M; Hassan ZM; Ghasemnejad H; Roshan-Milani S; Shahabi S
Microbes Infect; 2010 May; 12(5):382-8. PubMed ID: 20152926
[TBL] [Abstract][Full Text] [Related]
4. Delayed-type hypersensitivity and acquired cellular resistance in mice immunized with killed Listeria monocytogenes and adjuvants.
Van Der Meer C; Hofhuis FM; Willers JM
Immunology; 1979 May; 37(1):77-82. PubMed ID: 112043
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route.
Ravindran R; Maji M; Ali N
Mol Pharm; 2012 Jan; 9(1):59-70. PubMed ID: 22133194
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the immunogenicity and protective efficacy of killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis.
Thakur A; Kaur H; Kaur S
Med Microbiol Immunol; 2015 Aug; 204(4):539-50. PubMed ID: 25432859
[TBL] [Abstract][Full Text] [Related]
7. Anti-bacterial immunity to Listeria monocytogenes in allogeneic bone marrow chimera in mice.
Onoé K; Good RA; Yamamoto K
J Immunol; 1986 Jun; 136(11):4264-9. PubMed ID: 2871109
[TBL] [Abstract][Full Text] [Related]
8. CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen Listeria monocytogenes.
Rolph MS; Kaufmann SH
J Immunol; 2001 Apr; 166(8):5115-21. PubMed ID: 11290793
[TBL] [Abstract][Full Text] [Related]
9. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.
Schafer R; Portnoy DA; Brassell SA; Paterson Y
J Immunol; 1992 Jul; 149(1):53-9. PubMed ID: 1607662
[TBL] [Abstract][Full Text] [Related]
10. Immune privilege in the anterior chamber of the eye is not extended to intraocular Listeria monocytogenes.
Li XY; Niederkorn JY
Ocul Immunol Inflamm; 1997 Dec; 5(4):245-57. PubMed ID: 9455741
[TBL] [Abstract][Full Text] [Related]
11. Effect of cell wall skeleton and monophosphoryl lipid A adjuvant on the immunogenicity of a murine B16 melanoma vaccine.
Johnston D; Bystryn JC
J Natl Cancer Inst; 1991 Sep; 83(17):1240-5. PubMed ID: 1870150
[TBL] [Abstract][Full Text] [Related]
12. Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells.
Okamoto S; Kawabata S; Nakagawa I; Hamada S
Infect Immun; 2001 Nov; 69(11):6633-42. PubMed ID: 11598032
[TBL] [Abstract][Full Text] [Related]
13. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
14. Killed Listeria-induced suppressor T cells involved in suppression of delayed-type hypersensitivity and protection against Listeria infection.
Yamamoto K; Kato K; Kimura T
Immunology; 1985 Aug; 55(4):609-19. PubMed ID: 2410356
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
[TBL] [Abstract][Full Text] [Related]
16. Long-lived protective immunity to Listeria is conferred by immunization with particulate or soluble listerial antigen preparations coadministered with IL-12.
Miller MA; Skeen MJ; Ziegler HK
Cell Immunol; 1998 Mar; 184(2):92-104. PubMed ID: 9630835
[TBL] [Abstract][Full Text] [Related]
17. Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice.
Zimecki M; Kruzel ML
Immunol Lett; 2000 Nov; 74(3):183-8. PubMed ID: 11064098
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Cell Wall-Deficient Spheroplasts Against Experimental Murine Listeriosis.
Ansari MA; Zia Q; Kazmi S; Ahmad E; Azhar A; Johnson KE; Zubair S; Owais M
Scand J Immunol; 2015 Jul; 82(1):10-24. PubMed ID: 25833403
[TBL] [Abstract][Full Text] [Related]
19. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.
Rodriguez-Del Rio E; Marradi M; Calderon-Gonzalez R; Frande-Cabanes E; Penadés S; Petrovsky N; Alvarez-Dominguez C
Vaccine; 2015 Mar; 33(12):1465-73. PubMed ID: 25659269
[TBL] [Abstract][Full Text] [Related]
20. Transfer of both protection and delayed-type hypersensitivity against live Listeria is mediated by the CD8+ T cell subset: a study with Listeria-specific T lymphocytes recovered from murine infected liver.
Goossens PL; Marchal G; Milon G
Int Immunol; 1992 May; 4(5):591-8. PubMed ID: 1627496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
